US Patent Issued to SPINALCYTE on Feb. 10 for "Prevention and treatment of kidney failure by administration of fibroblasts and products thereof" (California, Texas Inventors)

ALEXANDRIA, Va., Feb. 11 -- United States Patent no. 12,544,408, issued on Feb. 10, was assigned to SPINALCYTE LLC (Houston).

"Prevention and treatment of kidney failure by administration of fibroblasts and products thereof" was invented by Pete O'Heeron (Houston) and Thomas Ichim (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure provides means, methods, and compositions of preventing, reducing, and treating kidney failure through the administration of fibroblasts, modified fibroblasts, and/or products derived from fibroblasts. The disclosure may also concern administration of fibroblasts prior to, concurrent with, or subsequent to administration of a nephrotoxic agent results in produ...